Nesri Padayatchi

9.5k total citations · 2 hit papers
131 papers, 4.4k citations indexed

About

Nesri Padayatchi is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Nesri Padayatchi has authored 131 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Infectious Diseases, 84 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Nesri Padayatchi's work include Tuberculosis Research and Epidemiology (96 papers), Pneumocystis jirovecii pneumonia detection and treatment (52 papers) and HIV/AIDS Research and Interventions (31 papers). Nesri Padayatchi is often cited by papers focused on Tuberculosis Research and Epidemiology (96 papers), Pneumocystis jirovecii pneumonia detection and treatment (52 papers) and HIV/AIDS Research and Interventions (31 papers). Nesri Padayatchi collaborates with scholars based in South Africa, United States and United Kingdom. Nesri Padayatchi's co-authors include Kogieleum Naidoo, Max R. O’Donnell, Amrita Daftary, Salim S. Abdool Karim, Gonasagrie Nair, Iqbal Master, Quarraisha Abdool Karim, Wafaa El‐Sadr, Navisha Dookie and Anneke Grobler and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Nesri Padayatchi

128 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

2010 478 citations Kogieleum Naidoo, Nesri Padayatchi et al. profile →
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care

2018 222 citations Navisha Dookie, Santhuri Rambaran et al. profile →

Peers

Countries citing papers authored by Nesri Padayatchi

Since Specialization

Citations

This map shows the geographic impact of Nesri Padayatchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nesri Padayatchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nesri Padayatchi more than expected).

Fields of papers citing papers by Nesri Padayatchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nesri Padayatchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nesri Padayatchi. The network helps show where Nesri Padayatchi may publish in the future.

Co-authorship network of co-authors of Nesri Padayatchi

This figure shows the co-authorship network connecting the top 25 collaborators of Nesri Padayatchi. A scholar is included among the top collaborators of Nesri Padayatchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nesri Padayatchi. Nesri Padayatchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity	Scientific Reports	Santhuri Rambaran, Lara Lewis et al.	3
2	Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection	BMC Immunology	Santhuri Rambaran, Lara Lewis et al.	5
3	The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis	International Journal of Infectious Diseases	Rubeshan Perumal, Kogieleum Naidoo et al.	4
4	Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field	Frontiers in Microbiology	Navisha Dookie, Nesri Padayatchi et al.	43
5	Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study	BMC Infectious Diseases	Stephanie Law, Olivia Oxlade et al.	4
6	Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid	The International Journal of Tuberculosis and Lung Disease	Nesri Padayatchi, Farzana Osman et al.	24
7	When to start treatment? Dilemma illustrated by a paediatric case of extensively drug-resistant tuberculosis of the central nervous system	South African Medical Journal	Hans L. Rieder, Nesri Padayatchi et al.	0
8	Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis	The Lancet Microbe	Camus Nimmo, James Millard et al.	63
9	Training social workers to enhance patient-centered care for drug-resistant TB-HIV in South Africa	Public Health Action	Jennifer Zelnick, Amrita Daftary et al.	10
10	Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications	Tuberculosis	Sharana Mahomed, Kogieleum Naidoo et al.	13
11	Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study	The International Journal of Tuberculosis and Lung Disease	Amrita Daftary, Nesri Padayatchi	8
12	Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa	JAIDS Journal of Acquired Immune Deficiency Syndromes	Max R. O’Donnell, Melendhran Pillay et al.	9
13	Adherence in the Treatment of Patients With Extensively Drug-Resistant Tuberculosis and HIV in South Africa	JAIDS Journal of Acquired Immune Deficiency Syndromes	Max R. O’Donnell, Allison Wolf et al.	36
14	Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection	Emerging infectious diseases	Max R. O’Donnell, Nesri Padayatchi et al.	83
15	Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa	Emerging infectious diseases	Max R. O’Donnell, Jennifer Zelnick et al.	1
16	Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa	Emerging infectious diseases	Max R. O’Donnell, Jennifer Zelnick et al.	17
17	High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.	PubMed	James C. M. Brust, Neel R. Gandhi et al.	77
18	Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis	American Journal of Respiratory and Critical Care Medicine	Susan E. Dorman, John L. Johnson et al.	184
19	The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis	American Journal of Respiratory and Critical Care Medicine	F A Sirgel, P. Bernard Fourie et al.	83
20	Relationship between self reporting of past history of anti-tuberculosis treatment and radiographic findings in multidrug-resistant tuberculosis.	PubMed	Nesri Padayatchi et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact